The purpose of this study was to explore and determine the optimal landmark for defining complete remission after intensive induction therapy that best correlates with long-term survival outcome among patients with newly diagnosed acute myeloid leukemia (AML).

Subjects:
Myeloid Neoplasia
This content is only available as a PDF.
Copyright © 2025 American Society of Hematology
2025

Article PDF first page preview

First page of Time to complete remission is an independent determinant of survival after intensive chemotherapy in AML
You do not currently have access to this content.
Sign in via your Institution